Write in a clean editor, then format for Diabetes and Vascular Disease Research in one click — DocuGuru applies the official SAGE template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Diabetes and Vascular Disease Research is a peer-reviewed journal published by SAGE, covering Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Cardiovascular Function and Risk Factors.
| Publisher | SAGE |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Diabetes and Vascular Disease Research. 2023;12(3):45–58.
Formats any DOI in Diabetes and Vascular Disease Research style. No sign-up. |
| Publishes research in | Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes Treatment and Management Cardiovascular Function and Risk Factors Diabetes Management and Research Adipokines, Inflammation, and Metabolic Diseases |
| ISSN | 1479-1641 |
| Citation impact (2-yr) | 2.68 |
| h-index | 76 |
| i10-index | 662 |
| Total citations | 29,585 |
| Open access | Yes |
| Top institutions publishing here | University of Leeds |
| Journal website | dvr.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Given the multi-faceted pathogenesis of atherosclerosis in type 2 diabetes mellitus (T2DM), it is likely that interventions to mitigate this risk must address cardiovascular (CV) risk factors beyond glucose itself. Sodium glucose cotransporter-2 (SGLT-2) inhibitors are newer antihyperglycaemic agents with apparent multiple effects. Inherent in their mode of action to decrease glucose reabsorption by the…
Traditional treatments for type 1 and type 2 diabetes are often associated with side effects, including weight gain and hypoglycaemia that may offset the benefits of blood glucose lowering. The kidneys filter and reabsorb large amounts of glucose, and urine is almost free of glucose in normoglycaemia. The sodium-dependent glucose transporter (SGLT)-2 in the early…
The aim of this study was to assess the performance of the Finnish Diabetes Risk Score as a screening tool for undetected type 2 diabetes (T2D), abnormal glucose tolerance (AGT) and metabolic syndrome in the general population. In a cross-sectional, population-based survey, a total of 4,622 subjects aged 45-74 years were invited to a health…
Metformin is now established as a first-line antidiabetic therapy for the management of type 2 diabetes. Its early use in treatment algorithms is supported by lack of weight gain, low risk of hypoglycaemia and its mode of action to counter insulin resistance. The drug's anti-atherosclerotic and cardioprotective effects have recently been confirmed in prospective and…
Type 2 diabetes mellitus is a pathology of heterogeneous etiology characterized by hyperglycemia resulting from lack of insulin action, insulin secretion, or both, and the population with diabetes mellitus is predicted to be about 439 million worldwide by 2030. Prolong diabetes has been related with microvascular complications especially diabetic nephropathy. DN is the most common…
